These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12694334)

  • 21. Involvement of TGF-beta signal for peritoneal sclerosing in continuous ambulatory peritoneal dialysis.
    Naiki Y; Maeda Y; Matsuo K; Yonekawa S; Sakaguchi M; Iwamoto I; Hasegawa H; Kanamaru A
    J Nephrol; 2003; 16(1):95-102. PubMed ID: 12649540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions.
    Sakata N; Imanaga Y; Meng J; Tachikawa Y; Takebayashi S; Nagai R; Horiuchi S; Itabe H; Takano T
    Atherosclerosis; 1998 Nov; 141(1):61-75. PubMed ID: 9863539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced glycation end products are associated with immature angiogenesis and peritoneal dysfunction in patients on peritoneal dialysis.
    Nakano T; Mizumasa T; Kuroki Y; Eriguchi M; Yoshida H; Taniguchi M; Masutani K; Tsuruya K; Kitazono T
    Perit Dial Int; 2020 Jan; 40(1):67-75. PubMed ID: 32063152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraperitoneal verapamil therapy in CAPD patients with peritoneal hypopermeability. Effects on ultrafiltration.
    Lamperi S; Carozzi S; Nasini MG; Canepa M; Zanin T
    ASAIO Trans; 1988; 34(3):425-8. PubMed ID: 3196541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth factors in continuous ambulatory peritoneal dialysis effluent. Their relation with peritoneal transport of small solutes.
    Lai KN; Lai KB; Szeto CC; Lam CW; Leung JC
    Am J Nephrol; 1999; 19(3):416-22. PubMed ID: 10393381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical detection of advanced glycation end products in human bladder with specific monoclonal antibody.
    Matsumoto K; Fujiwara Y; Nagai R; Yoshida M
    Int J Urol; 2009 Apr; 16(4):402-5; discussion 405-6. PubMed ID: 19425220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Permanent loss of ultrafiltration capacity of the peritoneum in long-term peritoneal dialysis: an epidemiological study.
    Slingeneyer A; Canaud B; Mion C
    Nephron; 1983; 33(2):133-8. PubMed ID: 6835460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds.
    Miyata T; Horie K; Ueda Y; Fujita Y; Izuhara Y; Hirano H; Uchida K; Saito A; van Ypersele de Strihou C; Kurokawa K
    Kidney Int; 2000 Jul; 58(1):425-35. PubMed ID: 10886591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term follow-up of body size indices, residual renal function, and peritoneal transport characteristics in continuous ambulatory peritoneal dialysis.
    Twardowski ZJ; Moore HL; Prowant BF; Satalowich R
    Adv Perit Dial; 2009; 25():155-64. PubMed ID: 19886338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in fluid and solute transport between diabetic and nondiabetic patients at the onset of CAPD.
    Serlie MJ; Struijk DG; de Blok K; Krediet RT
    Adv Perit Dial; 1997; 13():29-32. PubMed ID: 9360646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peritoneal rest may successfully recover ultrafiltration in patients who develop peritoneal hyperpermeability with time on continuous ambulatory peritoneal dialysis.
    Rodrigues A; Cabrita A; Maia P; Guimarães S
    Adv Perit Dial; 2002; 18():78-80. PubMed ID: 12402593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural and ultrastructural peritoneal membrane changes and permeability alterations during continuous ambulatory peritoneal dialysis.
    Verger C; Brunschvicg O; Le Charpentier Y; Lavergne A; Vantelon J
    Proc Eur Dial Transplant Assoc; 1981; 18():199-205. PubMed ID: 7329968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fas expression on peritoneal macrophages during continuous ambulatory peritoneal dialysis peritonitis.
    Chen CY; Wu CY; Tsai TC; Lin WT; Lee WJ; Su CC; Chen HC; Chiang HC
    Ren Fail; 2008; 30(3):297-301. PubMed ID: 18350449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal changes of peritoneal function calculated by personal dialysis capacity in a patient after long-term continuous ambulatory peritoneal dialysis.
    Nakamoto H; Takane H; Sugahara S; Kanno Y; Okada H; Yamamoto T; Suzuki H
    Adv Perit Dial; 2003; 19():97-102. PubMed ID: 14763042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
    Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
    Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro formation of N(epsilon)-(carboxymethyl)lysine and imidazolones under conditions similar to continuous ambulatory peritoneal dialysis.
    Tauer A; Knerr T; Niwa T; Schaub TP; Lage C; Passlick-Deetjen J; Pischetsrieder M
    Biochem Biophys Res Commun; 2001 Feb; 280(5):1408-14. PubMed ID: 11162688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage recognition of toxic advanced glycosylation end products through the macrophage surface-receptor nucleolin.
    Miki Y; Dambara H; Tachibana Y; Hirano K; Konishi M; Beppu M
    Biol Pharm Bull; 2014; 37(4):588-96. PubMed ID: 24818254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modification of peritoneal ultrafiltration capacity in children undergoing peritoneal dialysis.
    Drachman R; Niaudet P; Gagnadoux MF; Broyer M
    Int J Pediatr Nephrol; 1985; 6(1):35-40. PubMed ID: 3997371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced expression of TGF-beta 1 by peritoneal macrophages in CAPD patients.
    Wang T; Ghen YG; Ye RG; Mai WY; Zhen ZH; Li HQ
    Adv Perit Dial; 1995; 11():11-4. PubMed ID: 8534680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Technical note. The serum concentration of the advanced glycation end-product N epsilon-(carboxymethyl)lysine is increased in uremia.
    Degenhardt TP; Grass L; Reddy S; Thorpe SR; Diamandis EP; Baynes JW
    Kidney Int; 1997 Oct; 52(4):1064-7. PubMed ID: 9328946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.